New hope for kids with rare, aggressive brain cancers in early drug trial
Disease control
Not yet recruiting
This is a first-in-children study to find a safe dose of an experimental oral drug called gallium maltolate for kids whose aggressive brain tumors have returned or not responded to standard treatments. The main goal is to understand the drug's side effects and how the body proces…
Phase: PHASE1 • Sponsor: Sarah Rumler • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC